Vicki Norton

United States

Duane Morris LLP · Vicki G. Norton, Ph.D., has advised life sciences clients for 25 years, devising strategies for clients to successfully counter patent claims and demands totaling over $2 billion, performing IP diligence for transactions, product clearances, and at the market offerings collectively worth over $4.0 billion, and formulating worldwide patent strategies for clients entering public markets with total valuations of over $6 billion. Dr. Norton also audits technology portfolios and identifies patent coverage issues for her clients’ transactions, venture financings, and patent enforcement opportunities. She has handled patent matters in a variety of life science fields, including precision medicine and diagnostics, biologic drugs, pharmaceuticals, immuno-oncology, regenerative medicine and stem cell technologies, transgenic plants and cells, molecular biology, nanotechnology, combinatorial chemistry, probe amplification assays, nutraceuticals, microbiology, and devices for physical therapy. Dr. Norton has also advised clients on all facets of litigation involving technologies including diagnostics, biopharmaceuticals, transgenic organisms, small molecules and nanotechnology. Vicki Norton serves as a team lead for the Duane Morris Life Sciences and Medical Technologies industry group and is Chair of the Life Sciences, Pharmaceuticals, and Biotechnology Division of the firm's Intellectual Property Practice Group. Prior to attending law school, Dr. Norton served as a research and teaching assistant at the University of California, Davis, where she conducted research on histone acetylation and chromatin structure for her doctoral thesis.

United States